- 작성자 : ILIAS Biologics
- 작성일 : 21-02-03 17:38
- 조회 : 103회
22 Jan 2021
Science Advances highlights the 2nd Proof of Concept study of EXPLOR®
Our latest publication in Science Advances highlights a novel approach that can potentially save millions of lives of mothers and their babies with engineered exosome treatment. We are excited to present the discovery of a potential breakthrough in treating preterm birth that's still a major cause of infant death all over the world. This is the 2nd Proof of Concept study result that showed the expandability of our platform technology, EXPLOR®.
Chulhee Choi, CEO and CSO of ILIAS Biologics, Inc. said, “the study result suggests the possibility of the safe and effective treatment to prevent preterm birth by solving the problem of current medications─that cannot cross the placental barrier─with EXPLOR® technology and proves the enormous expandability of exosome-based treatment.”